Aclarion Announces Completion of First Nociscan Exams in LIFEHAB Trial
10. September 2024 06:57 ET | Aclarion, Inc.
Initial LIFEHAB Enrolled Patients Receive Nociscan Exams to Help Evaluate How Biomarkers in the Discs of the Lumbar Spine Correspond With Treatment Response LIFEHAB is a Randomized Controlled Trial...
Aclarion Announces First Commercial Agreement in Michigan
14. August 2024 08:08 ET | Aclarion, Inc.
Sheridan Community Hospital is the First Healthcare Institution in Michigan With Nociscan Agreement Expands Nociscan Access to John Keller, MD, a Leading Neurosurgeon and Aclarion Medical Advisor,...
Aclarion Announces Key Commercial Milestone With Completion of 1,000 Nociscan Exams
27. November 2023 08:00 ET | Aclarion, Inc.
Pace of Nociscan orders accelerated 2.5x for the last 250 scans compared to the first 250 scans Further acceleration of scan volumes expected as MRIs are activated for the recently completed panel...